Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.4M Sell
738,400
-204,400
-22% -$3.4M ﹤0.01% 2373
2025
Q4
$17M Buy
942,800
+467,500
+98% +$8.04M ﹤0.01% 1764
2025
Q3
$7.66M Buy
475,300
+337,800
+246% +$4.94M ﹤0.01% 2783
2025
Q2
$1.5M Buy
137,500
+118,700
+631% +$1.33M ﹤0.01% 4905
2025
Q1
$235K Sell
18,800
-4,900
-21% -$80.7K ﹤0.01% 8213
2024
Q4
$469K Buy
+23,700
New +$262K ﹤0.01% 6908
2021
Q1
Sell
-14,500
Closed -$251K 9402
2020
Q4
$251K Sell
14,500
-99,100
-87% -$2.44M ﹤0.01% 6659
2020
Q3
$4.13M Buy
113,600
+98,300
+642% +$3.08M ﹤0.01% 2067
2020
Q2
$343K Buy
+15,300
New +$328K ﹤0.01% 5638

Other funds holding MESO

Jane Street's MESO Position: Q1 2026 in Review

Jane Street reduced its Mesoblast (MESO) stake by 41% in Q1 2026, selling an estimated $1.14M and leaving 98,786 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #5614.

Jane Street first reported a position in MESO in Q1 2016 and has held it in 27 quarters since. The position peaked at $3.02M in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Jane Street held 98,786 shares of Mesoblast worth $1.52M as of Q1 2026.
  • Jane Street sold 68,594 Mesoblast shares in Q1 2026, an estimated $1.14M.
  • Mesoblast made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5614 holding.
  • Jane Street first reported a position in Mesoblast in Q1 2016 and has held it in 27 quarters since.
  • Jane Street's Mesoblast position peaked at $3.02M in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.